Investigational Site Number : 3923104
Edogawa City, Tokyo 133-0052
1 studies enrolling now · 1 studies all time
What they study most
Dermatitis Atopic
Studies at this site
Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials
— Enrolling by invitation